Clinical preference for factors in treatment of geriatric depression

Código QR

Clinical preference for factors in treatment of geriatric depression

Matthias W Riepe Mental Health and Geriatric Psychiatry, Psychiatry II, Ulm University, Ulm, Germany Abstract: Little is known about symptom preferences of clinical psychiatrists in the treatment of geriatric depression and preferences for avoiding adverse drug effects. Participants (bo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Riepe MW
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/0bdeb43578aa4a1b9061705e55cd9704
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Safety and effectiveness of controlled-release paroxetine in routine clinical practice: results of a postmarketing surveillance study of patients with depression
por: Kato M, et al.
Publicado: (2015)

Late- versus early-onset geriatric depression in a memory research center
por: Carol Dillon, et al.
Publicado: (2009)

Neuromodulation and antenatal depression: a review
por: Kim DR, et al.
Publicado: (2015)

Can low brain-derived neurotrophic factor levels be a marker of the presence of depression in obese women?
por: Celik Guzel E, et al.
Publicado: (2014)

Depressogenic medications and other risk factors for depression among Polish patients with epilepsy
por: Bosak M, et al.
Publicado: (2015)

Effect of depressive symptoms on the length of hospital stay among patients hospitalized for acute stroke in Japan
por: Sugawara N, et al.
Publicado: (2015)

Comparative efficacy of alemtuzumab and established treatment in the management of multiple sclerosis
por: Babij R, et al.
Publicado: (2015)

Is placebo useful in the treatment of major depression in clinical practice?
por: Marchesi C, et al.
Publicado: (2013)

Shen-Qi-Jie-Yu-Fang has antidepressant effects in a rodent model of postpartum depression by regulating the immune organs and subsets of T lymphocytes
por: Qu M, et al.
Publicado: (2015)

Comparison of paroxetine and agomelatine in depressed type 2 diabetes mellitus patients: a double-blind, randomized, clinical trial
por: Kang RY, et al.
Publicado: (2015)

Pharmacology and clinical potential of vortioxetine in the treatment of major depressive disorder
por: Alvarez E, et al.
Publicado: (2014)

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
por: Novick D, et al.
Publicado: (2015)

Effect of music intervention on the cognitive and depression status of senior apartment residents in Taiwan
por: Tai SY, et al.
Publicado: (2015)

Magnetic seizure therapy in an adolescent with refractory bipolar depression: a case report
por: Noda Y, et al.
Publicado: (2014)

Predictors of premature discontinuation of outpatient treatment after discharge of patients with posttraumatic stress disorder
por: Wang HR, et al.
Publicado: (2015)

The clinical basis of orthorexia nervosa: emerging perspectives
por: Koven NS, et al.
Publicado: (2015)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015)

Clinical utility of vilazodone for the treatment of adults with major depressive disorder and theoretical implications for future clinical use
por: Singh M, et al.
Publicado: (2012)

Telomere length in blood cells is related to the chronicity, severity, and recurrence rate of schizophrenia
por: Pawelczyk T, et al.
Publicado: (2015)

Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference
por: Steffen Naegel, et al.
Publicado: (2009)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Catha edulis chewing effects on treatment of paranoid schizophrenic patients
por: Kotb El-Sayed MI, et al.
Publicado: (2015)

The clinical psychologist and the management of inpatient pain: a small case series
por: Childs SR, et al.
Publicado: (2014)

&nbsp;Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group)
por: Abrahamian H, et al.
Publicado: (2012)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
por: David J Muzina
Publicado: (2009)

Neuroinflammatory responses to traumatic brain injury: etiology, clinical consequences, and therapeutic opportunities
por: Lozano D, et al.
Publicado: (2015)

Catatonia in Down syndrome; a treatable cause of regression
por: Ghaziuddin N, et al.
Publicado: (2015)

The severe complication of Stevens–Johnson syndrome induced by long-term clozapine treatment in a male schizophrenia patient: a case report
por: Wu MK, et al.
Publicado: (2015)

Epidemiology and treatment of post-stroke depression
por: Stefano Paolucci
Publicado: (2008)

Postpartum depression: psychoneuroimmunological underpinnings and treatment
por: Anderson G, et al.
Publicado: (2013)

Desvenlafaxine in the treatment of major depressive disorder
por: Maria Teresa C Lourenco1, et al.
Publicado: (2009)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
por: Delia Bishara, et al.
Publicado: (2009)

Korean Medication Algorithm for Bipolar Disorder 2014: comparisons with other treatment guidelines
por: Jeong JH, et al.
Publicado: (2015)

Efficacy and safety of intravenous nimodipine administration for treatment of hypertension in patients with intracerebral hemorrhage
por: Li YQ, et al.
Publicado: (2015)

Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults
por: Robert H Howland
Publicado: (2009)

Association of metabotropic glutamate receptor 3 gene polymorphisms with schizophrenia risk: evidence from a meta-analysis
por: Yang X, et al.
Publicado: (2015)

Persistent akathisia masquerading as agitated depression after use of ziprasidone in the treatment of bipolar depression
por: Penders TM, et al.
Publicado: (2013)

Transcranial magnetic stimulation for the treatment of major depression
por: Janicak PG, et al.
Publicado: (2015)

MicroRNA as therapeutic targets for treatment of depression
por: Hansen KF, et al.
Publicado: (2013)

Metric qualities of the cognitive behavioral assessment for outcome evaluation to estimate psychological treatment effects
por: Bertolotti G, et al.
Publicado: (2015)